C WorldWide Group Holding A/S - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 292 filers reported holding NOVOCURE LTD in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
C WorldWide Group Holding A/S ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$3,582
-61.1%
221,7840.0%0.05%
-58.8%
Q2 2023$9,204
-31.0%
221,7840.0%0.12%
-35.0%
Q1 2023$13,338
-38.7%
221,784
-25.3%
0.18%
-36.7%
Q4 2022$21,769
-99.9%
296,7840.0%0.29%
-7.1%
Q3 2022$22,550,000
+9.3%
296,7840.0%0.31%
+20.1%
Q2 2022$20,626,000
-16.1%
296,7840.0%0.26%
-3.4%
Q1 2022$24,589,000
+35.5%
296,784
+22.7%
0.27%
+56.7%
Q4 2021$18,153,000
+39.8%
241,784
+116.3%
0.17%
+28.6%
Q3 2021$12,986,000
-47.6%
111,7840.0%0.13%
-47.8%
Q2 2021$24,796,000
+48.0%
111,784
-11.8%
0.26%
+55.5%
Q1 2021$16,758,000
-40.1%
126,784
-21.6%
0.16%
-41.4%
Q4 2020$27,995,000
+4.0%
161,784
-33.1%
0.28%
-7.6%
Q3 2020$26,913,000
+32.8%
241,784
-29.3%
0.30%
+27.8%
Q2 2020$20,268,000
+80.5%
341,784
+104.9%
0.24%
+51.0%
Q1 2020$11,231,000
-20.1%
166,7840.0%0.16%
-6.5%
Q4 2019$14,055,000
+12.7%
166,7840.0%0.17%
+6.3%
Q3 2019$12,472,000
-5.2%
166,784
-19.8%
0.16%
-3.7%
Q2 2019$13,156,000
+152.8%
208,059
+92.5%
0.16%
+148.5%
Q1 2019$5,205,000
+10.2%
108,059
-23.4%
0.07%
-2.9%
Q4 2018$4,724,000
-45.3%
141,094
-14.5%
0.07%
-38.7%
Q3 2018$8,644,000
+29.6%
164,953
-22.6%
0.11%
+19.4%
Q2 2018$6,672,000
+81.8%
213,153
+26.6%
0.09%
+66.1%
Q1 2018$3,669,000
-4.8%
168,321
-11.8%
0.06%0.0%
Q4 2017$3,854,000
-15.8%
190,800
-17.2%
0.06%
-13.8%
Q3 2017$4,575,000
-3.3%
230,500
-15.8%
0.06%
-9.7%
Q2 2017$4,733,000273,6000.07%
Other shareholders
NOVOCURE LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$27,923,00010.09%
Darsana Capital Partners LP 1,700,000$100,810,0005.98%
HARTLINE INVESTMENT CORP/ 336,617$19,961,0004.18%
Rhenman & Partners Asset Management AB 375,000$22,238,0002.40%
MORGAN JESS S & CO INC 35,942$2,131,0002.31%
Soleus Capital Management, L.P. 56,397$3,344,0001.91%
Bullseye Asset Management LLC 45,161$2,678,0001.43%
Taylor Frigon Capital Management LLC 46,304$2,746,0001.36%
COURAGE CAPITAL MANAGEMENT LLC 10,000$593,0001.09%
Redwood Investments, LLC 192,986$11,444,0001.01%
View complete list of NOVOCURE LTD shareholders